Research Analysts Set Expectations for Teleflex Q3 Earnings

Teleflex Incorporated (NYSE:TFX - Free Report) - Zacks Research dropped their Q3 2025 EPS estimates for shares of Teleflex in a report released on Thursday, May 15th. Zacks Research analyst R. Department now expects that the medical technology company will post earnings of $3.37 per share for the quarter, down from their prior forecast of $3.54. The consensus estimate for Teleflex's current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex's Q2 2026 earnings at $3.93 EPS, Q3 2026 earnings at $3.80 EPS and Q1 2027 earnings at $3.67 EPS.

Teleflex (NYSE:TFX - Get Free Report) last posted its earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.88 by $0.03. The firm had revenue of $700.67 million during the quarter, compared to analyst estimates of $699.37 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Teleflex's revenue was down 5.0% on a year-over-year basis. During the same period in the previous year, the business posted $3.21 EPS.

TFX has been the topic of a number of other reports. Citizens Jmp downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. Needham & Company LLC restated a "hold" rating on shares of Teleflex in a research report on Wednesday, March 12th. Truist Financial dropped their price target on shares of Teleflex from $140.00 to $137.00 and set a "hold" rating on the stock in a research report on Monday, May 5th. Mizuho set a $155.00 price target on shares of Teleflex in a research report on Wednesday, April 16th. Finally, Royal Bank of Canada dropped their price target on shares of Teleflex from $150.00 to $145.00 and set a "sector perform" rating on the stock in a research report on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, Teleflex has an average rating of "Hold" and an average target price of $164.63.

Teleflex Stock Performance

Teleflex stock traded up $0.01 during midday trading on Monday, reaching $120.95. 504,858 shares of the stock traded hands, compared to its average volume of 634,351. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The firm has a fifty day moving average price of $131.43 and a two-hundred day moving average price of $160.11. The firm has a market cap of $5.34 billion, a price-to-earnings ratio of 24.05, a PEG ratio of 1.73 and a beta of 1.17. Teleflex has a fifty-two week low of $116.63 and a fifty-two week high of $249.91.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. CANADA LIFE ASSURANCE Co increased its position in shares of Teleflex by 0.4% in the fourth quarter. CANADA LIFE ASSURANCE Co now owns 20,320 shares of the medical technology company's stock worth $3,614,000 after acquiring an additional 74 shares in the last quarter. Hengehold Capital Management LLC increased its position in shares of Teleflex by 7.3% in the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company's stock worth $229,000 after acquiring an additional 88 shares in the last quarter. Exchange Traded Concepts LLC increased its position in shares of Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock worth $61,000 after acquiring an additional 94 shares in the last quarter. MassMutual Private Wealth & Trust FSB increased its position in shares of Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock worth $27,000 after acquiring an additional 100 shares in the last quarter. Finally, True Wealth Design LLC grew its position in Teleflex by 62.3% during the fourth quarter. True Wealth Design LLC now owns 271 shares of the medical technology company's stock valued at $48,000 after purchasing an additional 104 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 16th. Investors of record on Tuesday, May 20th will be issued a $0.34 dividend. The ex-dividend date of this dividend is Tuesday, May 20th. This represents a $1.36 dividend on an annualized basis and a dividend yield of 1.12%. Teleflex's payout ratio is currently 42.90%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.